| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Alx Oncology Holdings Inc. (ALXO) have been net sellers, shedding 2,803 shares worth roughly $5K on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.45M | $10.90M | - | |
| CEO | 294.4K | $379.7K | - | |
| VP | 87.8K | $113.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Shelly Pinto69 | SVP, Finance and CAO | Sell | 611 | $0.64 | $391.28 | -0.7% | +89.4% | +204.2% | |
| Aug 15, 2025 | Jason Lettmann74 | Chief Executive Officer | Sell | 2,382 | $0.64 | $1,525.43 | -1.1% | +89.4% | +204.2% | |
| Jul 7, 2025 | Shelly Pinto69 | SVP, Finance and CAO | Sell | 2,011 | $0.45 | $905.15 | -2.3% | +375.2% | +431.5% | |
| Jun 30, 2025 | Shelly Pinto69 | SVP, Finance and CAO | Sell | 1,532 | $0.43 | $658.76 | -1.7% | +321.6% | +398.7% | |
| Feb 19, 2025 | Shelly Pinto69 | SVP, Finance and CAO | Sell | 550 | $1.15 | $632.61 | -0.6% | -64.0% | +118.5% | |
| Feb 19, 2025 | Jaume Pons89 | President & CSO | Sell | 1,326 | $1.15 | $1,525.17 | -0.2% | -64.0% | +118.5% | |
| Feb 19, 2025 | Jason Lettmann74 | Chief Executive Officer | Sell | 2,159 | $1.15 | $2,483.28 | -1.3% | -64.0% | +118.5% | |
| Jan 6, 2025 | Shelly Pinto69 | Interim CFO | Sell | 2,221 | $1.80 | $3,997.80 | -2.5% | -70.1% | -39.7% | |
| Dec 30, 2024 | Shelly Pinto69 | Interim CFO | Sell | 1,426 | $1.58 | $2,253.37 | -1.6% | -62.5% | -28.3% | |
| Dec 30, 2024 | Jaume Pons89 | President & CSO | Sell | 10,796 | $1.58 | $17,059.84 | -1.8% | -62.5% | -28.3% |